<DOC>
	<DOCNO>NCT00842270</DOCNO>
	<brief_summary>The aim study evaluate , comparatively placebo , activity oral AB1010 , administer three dose level 4 month patient severe persistent corticosteroid dependent asthma , assess : - decrease corticosteroid therapy - asthma control improvement ( symptomatic score , rescue medication intake , respiratory function ) - pharmacokinetic profile AB1010 - clinical biological safety parameter</brief_summary>
	<brief_title>Efficacy Oral AB1010 Adult Patients With Severe Persistent Corticosteroid Dependent Asthma</brief_title>
	<detailed_description>This double-blind , placebo-controlled , randomize , parallel-groups , multicenter study daily oral AB1010 dose 3 , 4.5 6 mg/kg/day . The study treatment administer 16 week : - first 4 week run-in period corticosteroid remain stable ; - follow 8 week , corticosteroid decrease every week wean exacerbation occur ; - last 4 week stabilization period . Patients perform visit every 2 week run-in , every week follow 3 month .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<criteria>Known severe persistent corticosteroid dependent asthma ( WHO/NHLBI workshop definition ) . Disease duration &gt; 1 year . Stable disease exacerbation episode least one month inclusion . Daily treat 10 50 mg equivalent prednisolone , stable dosage since least 3 month . Known reversibility bronchial obstruction , define enhancement FEV1 â‰¥ 12 % , 10 minute salbutamol administration , 14 day systemic treatment 1 mg/kg/day equivalent prednisolone . Asthmatic patient still expose allergen trigger factor influence asthma control . History infection require hospitalization treatment antibiotic within 2 week screen .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>severe asthma</keyword>
	<keyword>corticosteroid dependent</keyword>
	<keyword>asthma exacerbation</keyword>
	<keyword>wean</keyword>
	<keyword>tyrosine kinase inhibitor</keyword>
	<keyword>severe persistent corticosteroid dependent asthma</keyword>
</DOC>